Michael Robin Witt
Chief Executive Officer at GABATHER AB
Michael Robin Witt active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GABATHER AB | Director/Board Member | 31/08/2014 | - |
| Chief Executive Officer | 30/09/2018 | - | |
| Investor Relations Contact | - | - | |
| Lead Discovery Malaysia Sdn. Bhd. | Chief Executive Officer | 31/12/2011 | - |
| Chief Tech/Sci/R&D Officer | 31/12/2011 | - |
Career history of Michael Robin Witt
Former positions of Michael Robin Witt
| Companies | Position | Start | End |
|---|---|---|---|
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Chief Tech/Sci/R&D Officer | 31/08/2010 | 31/03/2012 |
| Founder | 31/12/2006 | 31/03/2012 | |
| KARO PHARMA AB (PUBL) | Chief Tech/Sci/R&D Officer | 31/12/2001 | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - | - |
| NTG NORDIC TRANSPORT GROUP A/S | Corporate Officer/Principal | - | - |
Training of Michael Robin Witt
| Vrije Universiteit Brussel | Doctorate Degree |
| Danmarks Farmaceutiske Universitet | Doctorate Degree |
Statistics
International
| Sweden | 5 |
| Denmark | 3 |
| Belgium | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Transportation | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| KARO PHARMA AB (PUBL) | Health Technology |
| GABATHER AB | Health Technology |
| Private companies | 3 |
|---|---|
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
| Lead Discovery Malaysia Sdn. Bhd. |
- Stock Market
- Insiders
- Michael Robin Witt
- Experience
